GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 28, 2024
Displaying entries 3651 - 3700 of 39437 in total
PDB ID UniProt ID ▲ Title Descriptor
7FBJ 7FBJ Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6
7FBK 7FBK Crystal structure of SARS-CoV-2 receptor binding domain N501Y mutant in complex with neutralizing nanobody 20G6
7FBL 7FBL Thrombocorticin in complex with Ca2+ and mannose
7FBP 7FBP FXIIa-cMCoFx1 complex
7FCP 7FCP Crystallographic structure of two neutralizing antibodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
7FCQ 7FCQ Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
7FGB 7FGB A naturally-occurring neuraminidase-inhibitors-resistant NA from asiatic toad influenza B-like virus
7FGC 7FGC A naturally-occurring neuraminidase-inhibitors-resistant NA from asiatic toad influenza B-like virus
7FH0 7FH0 Crystallographic structure of two neutralizing nanobodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
7FIG 7FIG luteinizing hormone/choriogonadotropin receptor(S277I)-chorionic gonadotropin-Gs complex
7FJC 7FJC Crystal structure of SARS-CoV-2 Beta RBD complexed with P36-5D2 Fab
7FJN 7FJN Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab
7FJO 7FJO Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6 Fab
7FJS 7FJS Crystal structure of T6 Fab bound to theSARS-CoV-2 RBD of B.1.351
7JHG 7JHG Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody
7JHH 7JHH Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody
7JIX 7JIX Murine antibody that engages the influenza hemagglutinin receptor binding site
7JKS 7JKS Crystal structure of vaccine-elicited broadly neutralizing VRC01-class antibody 2411a in complex with HIV-1 gp120 core
7JKT 7JKT Crystal structure of vaccine-elicited broadly neutralizing VRC01-class antibody 2413a in complex with HIV-1 gp120 core
7JMO 7JMO Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04
7JMP 7JMP Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39
7JMW 7JMW Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab
7JN5 7JN5 Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022
7JOO 7JOO Crystal structure of ICOS in complex with antibody STIM003 and anti-kappa VHH domain
7JPH 7JPH Crystal structure of EBOV glycoprotein with modified HR1c and HR2 stalk at 3.2 A resolution
7JPI 7JPI Crystal structure of EBOV glycoprotein with modified HR2 stalk at 2.3A resolution
7JTG 7JTG Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody RM11-43
7JTR 7JTR Complex of maltose-binding protein (MBP) with single-chain Fv (scFv)
7JTV 7JTV Structure of IMPa from Pseudomonas aeruginosa in complex with an O-glycopeptide
7JV4 7JV4 SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
7JV6 7JV6 SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) SARS-CoV-2 spike glycoprotein, S2H13 Fab heavy chain, S2H13 Fab light chain
7JVA 7JVA SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains) S2A4 Fab heavy chain, S2A4 Fab light chain, SARS-CoV-2 spike glycoprotein
7JVC 7JVC SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment SARS-CoV-2 spike glycoprotein, S2A4 Fab heavy chain, S2A4 Fab light chain
7JVD 7JVD Fab of 5.6 monoclonal mouse IgG1 co-crystallized with the trisaccharide form of serotype 3 pneumococcal capsular polysaccharide
7JW0 7JW0 SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment SARS-CoV-2 spike glycoprotein, S304 Fab light chain, S304 Fab heavy chain
7JW4 7JW4 Crystal structure of PdGH110B in complex with D-galactose
7JWF 7JWF Crystal structure of PdGH110B D344N in complex with alpha-(1,3)-galactobiose
7JX3 7JX3 Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology
7JZ4 7JZ4 Crystal structure of broadly Plasmodium RIFIN reactive LAIR1-inserted antibody MGD21
7JZK 7JZK Crystal structure of LAIR1 ectodomain (from MGD21) in complex with Plasmodium RIFIN (PF3D7_0401300) V2 domain
7JZL 7JZL SARS-CoV-2 spike in complex with LCB1 (2RBDs open) Spike glycoprotein,LCB1
7JZM 7JZM SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3) LCB3,spike glycoprotein
7JZN 7JZN SARS-CoV-2 spike in complex with LCB3 (2RBDs open) Spike glycoprotein,LCB3
7JZU 7JZU SARS-CoV-2 spike in complex with LCB1 (local refinement of the RBD and LCB1) LCB1,Spike glycoprotein
7K0X 7K0X Marsupial T cell receptor Spl_145
7K0Z 7K0Z Marsupial T cell receptor Spl_157
7K37 7K37 Structure of full-length influenza HA with a head-binding antibody at pH 7.8 Hemagglutinin, antibody Fab light chain, antibody Fab heavy chain
7K39 7K39 Structure of full-length influenza HA with a head-binding antibody at pH 5.2, conformation A, neutral pH-like Hemagglutinin, antibody Fab light chain, antibody Fab heavy chain
7K3A 7K3A Structure of full-length influenza HA with a head-binding antibody at pH 5.2, conformation B, fusion peptide release Hemagglutinin, antibody Fab light chain, antibody Fab heavy chain
7K3B 7K3B Structure of full-length influenza HA with a head-binding antibody at pH 5.2, conformation C, central helices splay Hemagglutinin, antibody Fab light chain, antibody Fab heavy chain

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024